For research use only
| Cat No. | ABC-TC3842 |
| Product Type | Vascular Cells |
| Cell Type | Endothelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Umbillical Artery |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Umbilical Artery Endothelial Cells (HUAEC), isolated from human umbilical arteries, cryopreserved at second passage, ideal for vascular research.
uman Umbilical Artery Endothelial Cells (HUAECs), Neonatal are primary cells isolated from the umbilical artery of newborns. They exhibit a cobblestone-like appearance when confluent, typical of endothelial cells, and display a monolayer, polygonal shape in culture. HUAECs produce vasoactive mediators including nitric oxide (NO) and prostacyclin (PGI2), making them a valuable in vitro model for investigating endothelial function, vascular tone regulation, and barrier integrity. HUAECs are characterized by high expression of CD31. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | Human Umbilical Artery Endothelial Cells, Neonatal, HUAECs, Umbilical Artery ECs, Neonatal Arterial Endothelial Cells |
| Species | Human |
| Cat.No | ABC-TC3842 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Umbillical Artery |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Vascular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Umbilical Artery Endothelial Cells, Neonatal can be used to study endothelial function, including angiogenesis, vascular permeability, and inflammatory responses. They are employed to evaluate the effects of pharmaceuticals on endothelial barrier integrity, vasodilation, and oxidative stress responses. They are also used in tissue engineering to develop vascular grafts and bioengineered blood vessels, leveraging their proliferative capacity and ability to form tubular structures.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).